MapLight Therapeutics Valuation
| MPLT Stock | 17.60 0.33 1.91% |
At this time, the firm appears to be overvalued. MapLight Therapeutics secures a last-minute Real Value of USD16.48 per share. The latest price of the firm is USD17.6. Our model forecasts the value of MapLight Therapeutics from analyzing the firm fundamentals such as Number Of Shares Shorted of 1.37 M, current valuation of 562.43 M, and Shares Owned By Insiders of 48.88 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that MapLight Therapeutics' price fluctuation is somewhat reliable at this time. Calculation of the real value of MapLight Therapeutics is based on 3 months time horizon. Increasing MapLight Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
MapLight Therapeutics' intrinsic value may or may not be the same as its current market price of 17.60, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17.6 | Real 16.48 | Hype 17.22 | Naive 18.86 |
The intrinsic value of MapLight Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence MapLight Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of MapLight Therapeutics Common helps investors to forecast how MapLight stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MapLight Therapeutics more accurately as focusing exclusively on MapLight Therapeutics' fundamentals will not take into account other important factors: About MapLight Therapeutics Valuation
The stock valuation mechanism determines MapLight Therapeutics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of MapLight Therapeutics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of MapLight Therapeutics. We calculate exposure to MapLight Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of MapLight Therapeutics's related companies.Additional Tools for MapLight Stock Analysis
When running MapLight Therapeutics' price analysis, check to measure MapLight Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MapLight Therapeutics is operating at the current time. Most of MapLight Therapeutics' value examination focuses on studying past and present price action to predict the probability of MapLight Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MapLight Therapeutics' price. Additionally, you may evaluate how the addition of MapLight Therapeutics to your portfolios can decrease your overall portfolio volatility.